Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Avita Medical Inc (NQ: RCEL )

9.230 +0.540 (+6.21%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 159,022
Open 8.700
Bid (Size) 8.770 (1)
Ask (Size) 9.500 (5)
Prev. Close 8.690
Today's Range 8.700 - 9.480
52wk Range 4.410 - 11.00
Shares Outstanding 25,030,902
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AVITA Medical Announces Management Changes and Fourth Quarter 2022 Earnings Conference Call
From AVITA Medical
Via Globe NewsWire
Why Ontrak Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Ontrak, Inc. (NASDAQ: OTRK) shares jumped 101.7% to $1.1599 after the company announced new data that shows a reduction in depression and axiety symptoms for Ontrak Health's Wholehealth+... 
Via Benzinga

Performance

YTD
+43.10%
+43.10%
1 Month
+43.55%
+43.55%
3 Month
+84.23%
+84.23%
6 Month
+63.94%
+63.94%
1 Year
+3.36%
+3.36%

More News

Read More
AVITA Medical: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For August 11, 2022
Via Benzinga
Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Moderna, Tesla And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Via Benzinga
AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo
From AVITA Medical
Via Globe NewsWire
AVITA Medical Announces Results of 2022 Annual Meeting of Stockholders
From AVITA Medical
Via Globe NewsWire
AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair
From AVITA Medical
Via Globe NewsWire
AVITA Medical® to Present at the Piper Sandler 34th Annual Healthcare Conference
From AVITA Medical
Via Globe NewsWire
AVITA Medical® to Host Investor Webinar Briefing
From AVITA Medical
Via Globe NewsWire
AVITA Medical Reports Third Quarter 2022 Financial Results
From AVITA Medical
Via Globe NewsWire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 10, 2022
Via Benzinga
AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue Repair
From AVITA Medical
Via Globe NewsWire
AVITA Medical Announces FDA Breakthrough Device Designations for the RECELL® System
From AVITA Medical
Via Globe NewsWire
AVITA Medical to Announce Third Quarter 2022 Financial Results
From AVITA Medical
Via Globe NewsWire
AVITA Medical Appoints Industry Leader James Corbett as Chief Executive Officer
From AVITA Medical
Via Globe NewsWire
Investor Webinar Briefing (RCEL, AVH)
Via Newsfile
Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
Via Benzinga
AVITA Shares Climb Following Positive Results From RECELL System Study In Stable Vitiligo Lesions
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
AVITA Medical Shares Climb On Topline Results From Soft Tissue Reconstruction Study, Sees PMA Submission By Year-end
Via Benzinga
AVITA Medical: Q3 Earnings Insights
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.